Quarter Financials
Syndax Pharmaceuticals, Inc. (SNDX)
$24.74
+0.74 (+3.08%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | -38 | -37 | 96 | -21 | -23 | -28 | -20 | -20 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -618 | -581 | - | -640 | -619 | -596 | -569 | -548 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | - | - | -0 | - | - | - | - | - |
|---|
| Net PPE | 1 | 1 | - | 1 | 1 | 1 | 0 | 1 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | -19 | -129 | -67 | -60 | -63 | -105 | -42 | -122 |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|